83 related articles for article (PubMed ID: 7548767)
21. Inhibitory effect of 3'-untranslated region (3'-UTR) of human tissue-plasminogen activator (ht-PA) mRNA on its expression.
Ouyang Y; Huang P; Huang C
Sci China B; 1995 Oct; 38(10):1253-60. PubMed ID: 8554675
[TBL] [Abstract][Full Text] [Related]
22. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
24. A slow clearing, fibrin-specific, PAI-1 resistant variant of t-PA (T103N, KHRR 296-299 AAAA).
Paoni NF; Keyt BA; Refino CJ; Chow AM; Nguyen HV; Berleau LT; Badillo J; Peña LC; Brady K; Wurm FM
Thromb Haemost; 1993 Aug; 70(2):307-12. PubMed ID: 8236140
[TBL] [Abstract][Full Text] [Related]
25. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor?
Camani C; Gavin O; Kruithof EK
Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388
[TBL] [Abstract][Full Text] [Related]
26. Production of tissue-type plasminogen activator (t-PA) and type-1 plasminogen activator inhibitor (PAI-1) in mildly cirrhotic rat liver.
Seki T; Imai H; Uno S; Ariga T; Gelehrter TD
Thromb Haemost; 1996 May; 75(5):801-7. PubMed ID: 8725727
[TBL] [Abstract][Full Text] [Related]
27. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.
Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D
Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424
[TBL] [Abstract][Full Text] [Related]
28. High-density mutagenesis by combined DNA shuffling and phage display to assign essential amino acid residues in protein-protein interactions: application to study structure-function of plasminogen activation inhibitor 1 (PAI-I).
Stoop AA; Jespers L; Lasters I; Eldering E; Pannekoek H
J Mol Biol; 2000 Sep; 301(5):1135-47. PubMed ID: 10966811
[TBL] [Abstract][Full Text] [Related]
29. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH
Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
[TBL] [Abstract][Full Text] [Related]
30. Deletion of residues K296-G302 from the slowly-cleared tissue-type plasminogen activator t-PA del (G) leads to partial loss of plasminogen activating activity.
Dodd I; Browne MJ; Chapman CG; Cronk D; Hastwell C; Wilson S; Robinson JH
Biologicals; 1993 Sep; 21(3):269-74. PubMed ID: 8117440
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
32. [Changes in t-PA, PAI-1 gene expression of coronary arteries with preconditioning in acute myocardial infarction rat].
Zhu G; Wu W; Duan Y; Zhang Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Oct; 19(5):319-24. PubMed ID: 10453514
[TBL] [Abstract][Full Text] [Related]
33. Homology modeling of tissue-type plasminogen activator K1 domain and studies on the interactions between kringles and lysine.
Wang G; Liu S; Xu X; Huang P; Huang C
Chin J Biotechnol; 1998; 14(1):17-24. PubMed ID: 9759541
[TBL] [Abstract][Full Text] [Related]
34. Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1.
Bijnens AP; Ngo TH; Gils A; Dewaele J; Knockaert I; Stassen JM; Declerck PJ
Thromb Haemost; 2001 May; 85(5):866-74. PubMed ID: 11372681
[TBL] [Abstract][Full Text] [Related]
35. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
[TBL] [Abstract][Full Text] [Related]
36. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.
Declerck PJ; Verstreken M; Collen D
Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator and plasminogen activator inhibitor gene expression in human saphenous vein organ culture.
Javed Q; Swanson N; Warner EL; Gershlick AH; de Bono DP
Exp Mol Pathol; 2001 Apr; 70(2):146-53. PubMed ID: 11263957
[TBL] [Abstract][Full Text] [Related]
38. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
Grailhe P; Boyer-Neumann C; Haverkate F; Grimbergen J; Larrieu MJ; Anglés-Cano E
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):679-87. PubMed ID: 8292717
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated expression and packaging of tissue-type plasminogen activator in megakaryocytic cells.
Chuang JL; Schleef RR
Thromb Haemost; 2001 Jun; 85(6):1079-85. PubMed ID: 11434688
[TBL] [Abstract][Full Text] [Related]
40. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
